Any way you look at it, it is most likely the world will be a different place once some sense of normality resumes following the global battle against coronavirus. In the new paradigm, there will also be companies riding the wave of a successful confrontation with COVID-19. Will small cap biotech Cytosorbents (CTSO) make such a list?Bucking the trend, the healthcare company skyrocketed 70% year-to-date, on the back of a possible treatment for coronavirus.Last week, Cytosorbents announced...

Comment

Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch